Schinzel-Giedion syndrome: a rare cause of psychomotor delay and refractory seizures
Schinzel-Giedion syndrome (SGS) is a rare genetic syndrome characterized by severe developmental delay, facial dysmorphism, seizures, and multiple congenital malformations. Affected children have increased risk of developing neuroepithelial brain tumors.We are reporting a case of a 20 months-old boy...
| Published in: | Global Pediatrics |
|---|---|
| Main Authors: | Gordana Kovačević, Ružica Kravljanac, Biljana Vučetić Tadić, Slavica Ostojić, Seung Woo Ryu |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667009723000908 |
Similar Items
Novel SETBP1 D874V adjacent to the degron causes canonical schinzel–giedion syndrome: a case report and review of the literature
by: Jing Zheng, et al.
Published: (2024-05-01)
by: Jing Zheng, et al.
Published: (2024-05-01)
Case Report: Prolonged survival in Schinzel–Giedion syndrome featuring megaureter and de novo SETBP1 mutation
by: Glenda M. Beaman, et al.
Published: (2025-03-01)
by: Glenda M. Beaman, et al.
Published: (2025-03-01)
Acrocallosal Syndrome (Schinzel Syndrome)
by: J Gordon Millichap
Published: (1988-03-01)
by: J Gordon Millichap
Published: (1988-03-01)
World-Renowned “Swiss” Pediatricians, Their Syndromes, and Matching Imaging Findings: A Historical Perspective
by: Laura M. Huisman, et al.
Published: (2023-10-01)
by: Laura M. Huisman, et al.
Published: (2023-10-01)
Putative Roles of SETBP1 Dosage on the SET Oncogene to Affect Brain Development
by: Lilit Antonyan, et al.
Published: (2022-05-01)
by: Lilit Antonyan, et al.
Published: (2022-05-01)
Characteristics of Developmental and Epileptic Encephalopathy Associated with <i>PACS2</i> p.Glu209Lys Pathogenic Variant—Our Experience and Systematic Review of the Literature
by: Adina Stoian, et al.
Published: (2024-02-01)
by: Adina Stoian, et al.
Published: (2024-02-01)
Developmental encephalopathy and epilepsy associated with a heterozygous de novo mutation in the IRF2BPL gene: a case report
by: N. G. Lyukshina, et al.
Published: (2021-07-01)
by: N. G. Lyukshina, et al.
Published: (2021-07-01)
Developmental epileptic encephalopathy caused by homozygosity of a c.172+1G>C variant in the WWOX gene
by: Yang You, et al.
Published: (2024-08-01)
by: Yang You, et al.
Published: (2024-08-01)
Developmental Outcome Following Hemispherectomy for Hemimegalencephaly
by: J Gordon Millichap
Published: (2013-09-01)
by: J Gordon Millichap
Published: (2013-09-01)
Gene variations of glutamate metabolism pathway and epilepsy
by: Yan Feng, et al.
Published: (2022-06-01)
by: Yan Feng, et al.
Published: (2022-06-01)
Severe <i>KCNT1</i>-related developmental and epileptic encephalopathy
by: A. G. Malov, et al.
Published: (2025-07-01)
by: A. G. Malov, et al.
Published: (2025-07-01)
NEURODEVELOPMENTAL DISORDERS IN CHILDREN WITH EPILEPSY
by: N. N. Zavadenko
Published: (2016-06-01)
by: N. N. Zavadenko
Published: (2016-06-01)
Intrafamilial neurological phenotypic variability due to either biallelic or monoallelic pathogenic variants in CACNA1A
by: Dilbar Mammadova, et al.
Published: (2024-10-01)
by: Dilbar Mammadova, et al.
Published: (2024-10-01)
Infantile epileptic spasm syndrome: predictors of short- and long-term outcomes
by: Mohammed A. Al-Omari, et al.
Published: (2025-06-01)
by: Mohammed A. Al-Omari, et al.
Published: (2025-06-01)
Mental health intervention for a child with developmental and/or epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS)
by: C. Reilly, et al.
Published: (2025-09-01)
by: C. Reilly, et al.
Published: (2025-09-01)
Clinical phenotypes of developmental and epileptic encephalopathy-related recurrent KCNH5 missense variant p.R327H in Chinese children
by: Sheng Huang, et al.
Published: (2024-01-01)
by: Sheng Huang, et al.
Published: (2024-01-01)
Efficacy of anti‐seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1‐related epilepsy: A systematic review
by: Mathilde Gras, et al.
Published: (2024-08-01)
by: Mathilde Gras, et al.
Published: (2024-08-01)
Long‐term outcomes of a cohort of patients with pharmacoresistant neonatal epilepsy and negative brain MRI
by: Thibault Beretti, et al.
Published: (2025-10-01)
by: Thibault Beretti, et al.
Published: (2025-10-01)
Dynamics of management of monogenic epilepsies, developmental and epileptic encephalopathies in routine clinical practice
by: О. A. Rakhmanina, et al.
Published: (2025-01-01)
by: О. A. Rakhmanina, et al.
Published: (2025-01-01)
Genome-based therapeutics: Era of precision medicine in genetic epilepsies and epileptic encephalopathies
by: Aarthi Balaji, et al.
Published: (2023-01-01)
by: Aarthi Balaji, et al.
Published: (2023-01-01)
Customized targeted massively parallel sequencing enables the identification of novel pathogenic variants in Tunisian patients with developmental and epileptic encephalopathy
by: Mariem Ben Said, et al.
Published: (2024-10-01)
by: Mariem Ben Said, et al.
Published: (2024-10-01)
Epidemiology and etiology of infantile developmental and epileptic encephalopathies in Tasmania
by: Tyson L. Ware, et al.
Published: (2019-09-01)
by: Tyson L. Ware, et al.
Published: (2019-09-01)
First report of Tunisian patients with CDKL5‐related encephalopathy
by: Chahnez Charfi Triki, et al.
Published: (2024-06-01)
by: Chahnez Charfi Triki, et al.
Published: (2024-06-01)
Clinical analysis and functional characterization of KCNQ2-related developmental and epileptic encephalopathy
by: Jia Ye, et al.
Published: (2023-07-01)
by: Jia Ye, et al.
Published: (2023-07-01)
Through the Lens of Sigfried Giedion. Exploring Modernism and the Greek Vernacular in Situ
by: Kousidi, Matina
Published: (2017-04-01)
by: Kousidi, Matina
Published: (2017-04-01)
CCDC22 mutations that impair COMMD binding cause attenuated 3C/Ritscher-Schinzel syndrome
by: Amika Singla, et al.
Published: (2025-05-01)
by: Amika Singla, et al.
Published: (2025-05-01)
Drosophila melanogaster as a rapid in vivo assay system for preclinical anti‐seizure medication testing
by: Emma V. Töfflinger, et al.
Published: (2025-08-01)
by: Emma V. Töfflinger, et al.
Published: (2025-08-01)
Genetic epilepsy caused by CDKL5 gene mutations as an example of epileptic encephalopathy and developmental encephalopathy: literature review and own observations
by: K. Yu. Mukhin, et al.
Published: (2021-07-01)
by: K. Yu. Mukhin, et al.
Published: (2021-07-01)
ARV1 p.Gln62Ter, a novel mutation linked to developmental and epileptic encephalopathy-38
by: Mostafa Neissi, et al.
Published: (2025-02-01)
by: Mostafa Neissi, et al.
Published: (2025-02-01)
Clinical and genetic analysis of 18 patients with KCNQ2 mutations from South China
by: Binbin Cao, et al.
Published: (2024-05-01)
by: Binbin Cao, et al.
Published: (2024-05-01)
Voltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies
by: Khadijeh Shabani, et al.
Published: (2024-10-01)
by: Khadijeh Shabani, et al.
Published: (2024-10-01)
Mutation in the <i>STXBP1</i> Gene Associated with Early Onset West Syndrome: A Case Report and Literature Review
by: Kanako Takeda, et al.
Published: (2022-09-01)
by: Kanako Takeda, et al.
Published: (2022-09-01)
Neurodevelopmental defects in Dravet syndrome Scn1a+/− mice: Targeting GABA-switch rescues behavioral dysfunctions but not seizures and mortality
by: Lara Pizzamiglio, et al.
Published: (2025-04-01)
by: Lara Pizzamiglio, et al.
Published: (2025-04-01)
Landscape of genetic infantile epileptic spasms syndrome—A multicenter cohort of 124 children from India
by: Balamurugan Nagarajan, et al.
Published: (2023-12-01)
by: Balamurugan Nagarajan, et al.
Published: (2023-12-01)
Developmental and Epileptic Encephalopathy 76: Case Report and Review of Literature
by: Xiaodi Han, et al.
Published: (2022-12-01)
by: Xiaodi Han, et al.
Published: (2022-12-01)
KV7.2 channel dysfunction delays neuronal maturation and undermines early network development in a hiPSC model of KCNQ2-DEE
by: Filip Rosa, et al.
Published: (2025-11-01)
by: Filip Rosa, et al.
Published: (2025-11-01)
De Novo HNRNPU Pathogenic Variant Related to Developmental Epileptic Encephalopathy With Inherited KANSL1 Loss‐of‐Function Variant Resolved by RNA Analysis
by: Daria Akimova, et al.
Published: (2025-09-01)
by: Daria Akimova, et al.
Published: (2025-09-01)
Long‐term effectiveness and tolerability of ketogenic diet therapy in patients with genetic developmental and epileptic encephalopathy onset within the first 6 months of life
by: Tianyu Song, et al.
Published: (2024-04-01)
by: Tianyu Song, et al.
Published: (2024-04-01)
Add-on ketogenic diet versus antiseizure medications alone in children with developmental and epileptic encephalopathies: a prospective comparative cohort study
by: Wandong Hu, et al.
Published: (2025-10-01)
by: Wandong Hu, et al.
Published: (2025-10-01)
New variants and genotype-phenotype correlation of PPP3CA-related developmental and epileptic encephalopathy
by: Ting Wang, et al.
Published: (2025-06-01)
by: Ting Wang, et al.
Published: (2025-06-01)
Similar Items
-
Novel SETBP1 D874V adjacent to the degron causes canonical schinzel–giedion syndrome: a case report and review of the literature
by: Jing Zheng, et al.
Published: (2024-05-01) -
Case Report: Prolonged survival in Schinzel–Giedion syndrome featuring megaureter and de novo SETBP1 mutation
by: Glenda M. Beaman, et al.
Published: (2025-03-01) -
Acrocallosal Syndrome (Schinzel Syndrome)
by: J Gordon Millichap
Published: (1988-03-01) -
World-Renowned “Swiss” Pediatricians, Their Syndromes, and Matching Imaging Findings: A Historical Perspective
by: Laura M. Huisman, et al.
Published: (2023-10-01) -
Putative Roles of SETBP1 Dosage on the SET Oncogene to Affect Brain Development
by: Lilit Antonyan, et al.
Published: (2022-05-01)
